ketorolac
ketorolac: developed by 1 company · 9 clinical trials tracked · 1 FDA decision.
ketorolac evidence translation
What we can confirm
1 FDA record · 9 tracked trials
What it means
What to watch
Prepared research question
How could ketorolac → ABBV affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 4 study sponsors
Development Pipeline (1)
| Company | Phase |
|---|---|
| AbbVie Inc. (ABBV) | Approved |
Clinical Trials (9)
Postoperative Pain Outcomes After Use of Bupivacaine-Meloxicam Extended-Release Solution in Robot Assisted Total Knee Arthroplasty: A Prospective Study
Primary endpoint: Amount of opioid medications used (measured in morphine milligrams equivalents)
Optimizing Pain Treatment in Children On Mechanical Ventilation
Primary endpoint: Acute Pain Episodes
Efficacy of Ropivacaine Epinephrine Clonidine Ketorolac (R.E.C.K) vs Exparel in Robotic Nephrectomy: a Randomized, Prospective Trial
Primary endpoint: Area Under the Curve (AUC) of the Numeric Rating Scale (NRS) pain intensity scores through 7 days (168 hours) for participants receiving Exparel vs. R.E.C.K.
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
Primary endpoint: Chronic Opioid Use
Efficacy of Nasal Migraine Cocktail Used In Pediatric Emergency Department: A Clinical Trial
Primary endpoint: Change from baseline in pain on the 10 point Faces Pain Scale-Revised in 2 hours
NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis: A Randomized, Controlled Trial
Primary endpoint: Visual Analogue Scale (VAS) of Pain
Multimodal Nonopioid Pain Protocol Following Shoulder Arthroplasty Surgery
Primary endpoint: Pain Levels
INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy (INSPIRE) Study
Primary endpoint: PGE2 level during Diabetic Retinopathy progression
A Phase 2, Open-Label Study of HTX 011 in a Multimodal Analgesic Regimen for Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
Primary endpoint: Percentage of Subjects Receiving no Opioid Rescue
FDA Decisions1 records
Frequently asked questions
Who is developing ketorolac?
ketorolac is being developed by AbbVie Inc..
How many clinical trials involve ketorolac?
BioSniper tracks 9 clinical trials involving ketorolac.
What is ketorolac's latest FDA decision?
The most recent tracked FDA decision for ketorolac is Approval for 1 INDICATIONS AND USAGE ACUVAIL ® is indicated for the treatment of pain and inflammation following cataract surgery. ACUVAIL is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain and inflammation following cataract surgery. ( 1 ), dated July 22, 2009.